VLPDVFIRCV
VLPDVFIRCV, a melanoma antigen-derived peptide, is the intron sequence (nt 38-67) of the N-acetylglucosamine transferase V (GnT-V) gene. VLPDVFIRCV has a high affinity for MHC-I class molecules, but it cannot activate the immune response against natural tumor cells. The cytotoxic T lymphocytes (CTL) induced by VLPDVFIRCV can specifically lyse T2 cells loaded with this peptide in the chromium release experiment. VLPDVFIRCV can be used for vaccine design research[1].
Product Specifications
CAS Number
176510-49-9
UNSPSC
12352209
Target
MHC
Related Pathways
Immunology/Inflammation
Field of Research
Cancer
Smiles
Molecular Formula
C54H89N13O13S
Molecular Weight
1160.43
References & Citations
[1]Nolte A, et al. Generation of melanoma-specific cytotoxic T lymphocytes for allogeneic immunotherapy. J Immunother. 2003 May-Jun;26 (3) :257-69.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Bcas2 sgRNA CRISPR Lentivector (Rat) (Target 2)
